DGAT2 inhibition blocks SREBP-1 cleavage and improves hepatic steatosis by increasing phosphatidylethanolamine in the ER is a research paper published in Cell Metabolism (2024). On theSindex it has a DataRank of 0. It has been cited 96 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Leducq Foundation
Grant: 19CVD04
Welch Foundation
Grant: I-1793
Science and Technology Commission of Shanghai Municipality
Grant: 23ZR1411000
NIH
Grant: P30DK127984
NIH
Grant: UL1TR003163
NIH
Grant: P01HL-160487
NIH
Grant: AI-158357
NHLBI NIH HHS
Grant: P01 HL160487
NIDDK NIH HHS
Grant: T32 DK007745
NIAID NIH HHS
Grant: R01 AI158357
National Institutes of Health
Grant: 5UL1TR003163-05
UT Southwestern Center for Translational Medicine
National Institutes of Health
Grant: 1P01HL160487-01
New Approaches to Reduce Residual Cardiovascular Risk
National Institutes of Health
Grant: 5R01AI158357-03
Oxysterol Regulation of Microbial Pathogenesis
National Institutes of Health
Grant: 1P30DK127984-01A1
UT Southwestern NORC
Pfizer
Merck
FWCI
19.89
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals